| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.21▲ | 5.25▼ | 5.28▼ | 5.33▼ | 5.91▼ |
| MA10 | 5.22▲ | 5.30▼ | 5.30▼ | 5.43▼ | 6.10▼ |
| MA20 | 5.23▼ | 5.31▼ | 5.29▼ | 5.77▼ | 5.93▼ |
| MA50 | 5.30▼ | 5.32▼ | 5.34▼ | 6.08▼ | 4.54▲ |
| MA100 | 5.31▼ | 5.36▼ | 5.60▼ | 5.88▼ | 3.87▲ |
| MA200 | 5.30▼ | 5.65▼ | 6.02▼ | 4.72▲ | 3.37▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.012▼ | -0.003▼ | -0.060▼ | -0.168▼ |
| RSI | 41.333▼ | 37.371▼ | 38.685▼ | 38.887▼ | 47.691▼ |
| STOCH | 42.376 | 25.319 | 32.672 | 15.586▼ | 46.447 |
| WILL %R | -38.462 | -81.395▼ | -60.526 | -90.000▼ | -82.374▼ |
| CCI | -46.310 | -167.004▼ | -149.251▼ | -82.921 | -80.356 |
| ▼ MA | $TARA MA(20) Crossed Below MA(50) | Set Alert |
|
Tuesday, March 10, 2026 02:33 PM
Reported interim data from ADVANCED-2 trial in non-muscle invasive bladder cancer (NMIBC); TARA-002 demonstrated 68% complete response rate at six months in BCG-Unresponsive patients Company expects ...
|
|
Sunday, March 01, 2026 06:00 PM
Protara Therapeutics (NASDAQ:TARA) executives outlined progress across the company’s two clinical-stage programs during a fireside chat at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference ...
|
|
Wednesday, February 25, 2026 01:37 AM
Protara Therapeutics (NASDAQ:TARA) shared updated interim data from its ongoing Phase 2, open-label ADVANCED-2 trial evaluating intravesical TARA-002 in patients with high-risk non-muscle invasive ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/03/26 | 5.30 | 5.395 | 5.175 | 5.21 | 3,216,329 |
| 19/03/26 | 5.23 | 5.45 | 5.06 | 5.30 | 481,362 |
| 18/03/26 | 5.40 | 5.455 | 5.18 | 5.27 | 518,167 |
| 17/03/26 | 5.41 | 5.46 | 5.33 | 5.45 | 537,373 |
| 16/03/26 | 5.32 | 5.49 | 5.3156 | 5.42 | 673,616 |
| 13/03/26 | 5.35 | 5.49 | 5.24 | 5.26 | 692,404 |
| 12/03/26 | 5.51 | 5.515 | 5.21 | 5.32 | 874,263 |
| 11/03/26 | 5.65 | 5.705 | 5.42 | 5.60 | 748,727 |
| 10/03/26 | 5.87 | 6.07 | 5.65 | 5.71 | 1,256,552 |
| 09/03/26 | 5.53 | 5.835 | 5.43 | 5.75 | 1,173,930 |
|
|
||||
|
|
||||
|
|